Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agarose Bead Technologies is a private bioprocessing company that develops and manufactures agarose-based chromatography resins, magnetic beads, columns, and custom purification media for the biopharmaceutical industry. The company focuses on downstream processing and purification rather than drug discovery, supplying products used from research and process development through commercial-scale cGMP manufacturing. Its resins are used in purification workflows supporting monoclonal antibodies, recombinant proteins, vaccines, lipid nanoparticles, oligonucleotides, and cell and gene therapy products. ABT emphasizes custom resin development, scalable manufacturing, and quality systems including ISO 9001:2015-certified operations. The company has expanded manufacturing capacity in Spain and operates with a commercial footprint spanning Europe and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agarose Bead Technologies.